Your browser doesn't support javascript.
COVID-19 with baricitinib-induced symptomatic creatinine kinase elevation.
Saishoji, Y; Izumi, Y; Otsuka, Y; Yura, H.
  • Saishoji Y; From the Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki 856-8562, Japan.
  • Izumi Y; From the Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki 856-8562, Japan.
  • Otsuka Y; From the Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki 856-8562, Japan.
  • Yura H; Department of Respiratory disease, National Hospital Organization Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki 856-8562, Japan.
QJM ; 115(3): 155-156, 2022 03 22.
Article in English | MEDLINE | ID: covidwho-1764652

Full text: Available Collection: International databases Database: MEDLINE Main subject: Azetidines / COVID-19 Drug Treatment Limits: Humans Language: English Journal: QJM Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Qjmed

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Azetidines / COVID-19 Drug Treatment Limits: Humans Language: English Journal: QJM Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Qjmed